Protai
Dr. Moll is a serial drug hunter focused on cancer research and preclinical development with over twenty years experience in leadership positions in big pharma such as Pharmacia, Pfizer, Boehringer-Ingelheim, and Sanofi. His expertise lies in both cancer cell targeted and IO assets, using different modalities such as small molecules, antibodies and nanobodies. He has a proven track record of initiating and progressing targets and drugs in Oncology.
This person is not in the org chart
This person is not in any offices
Protai
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.